Propranolol

Initiating infantile hemangioma treatment with propranolol 2 mg/kg per day did not yield more adverse events than 1 mg/kg per day, according to a study.

Children and young adults with autism spectrum disorder experienced reduced anxiety symptoms after 12 weeks of treatment with the BP medication propranolol vs. placebo, though it did not improve scores for social interaction and language.

A 76-year-old man makes an appointment for an evaluation of shakiness.

Researchers observed no differences in rates of cesarean delivery among women with prolonged labor who were administered propranolol vs. placebo, findings presented at The Pregnancy Meeting showed.

Although COVID-19 remained a popular topic among Healio Primary Care readers in 2021, other stories that discussed diabetes screening and physician suicide also generated significant attention.

Propranolol treatment for a duration of two years is recommended for patients with segmental facial hemangiomas, according to a research letter published in the Journal of the American Academy of Dermatology.

The beta-blocker propranolol showed potential in treating certain autism symptoms, according to an initial analysis of a small, double-blinded, placebo-controlled trial.

Researchers discovered a method to evaluate the cutaneous biomarkers of atopic dermatitis using minimally invasive tape strips, which may offer insight into tracking pediatric treatment responses in the future, in the top pediatric dermatology story at Healio.

In the most popular Healio Dermatology story last week, mean hair density and hair caliber improved in a group of 30 women with androgenetic alopecia after platelet-rich plasma injections.

The common historical approach of “wait and see” for infantile hemangiomas can lead to bad outcomes, according to Lawrence A. Schachner, MD, a dermatologist and pediatrician.